Navigation Links
Cystic fibrosis patients' self-assessment of health can predict prognosis
Date:12/28/2008

Adult Cystic Fibrosis patients can provide important information that helps to predict their prognosis, according to research that asked 223 adult CF patients to assess their own health and well-being.

"We wished to see whether patients themselves had clinically relevant insight to their disease, and we found that they did," said lead author of the study, Janice Abbott, Ph.D., of the University of Central Lancashire in England.

The study was published in the first issue for January of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Prof. Abbott and colleagues administered 223 CF patients the cystic fibrosis health-related quality of life questionnaire (or CFQoL), a validated self-assessment tool, then followed them for 10 years. Patient outcomes were analyzed with respect to their initial self-assessment of their quality of life. After controlling for demographic factors and the severity of the disease, researchers found that several domains of patient-reported quality of life can help to predict mortality. The most important aspects were perceived physical functioning and the presence of pain. Specifically, patients reporting a lower quality of life were more likely to die sooner than those who perceived their quality of life to be higher.

"The most surprising result was the importance of patient-reported pain in predicting survival in cystic-fibrosis," wrote Dr. Abbott. "This work provides credibility for the use of patient-reported measures in clinical trials in CF, as it provides evidence that patient-reported outcomes can predict mortality."


'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary
2. Scientists Spot Key to Cystic Fibrosis Infections
3. Intervention in infants with cystic fibrosis key to slowing progression
4. Estrogen May Explain Why Women With Cystic Fibrosis Suffer More
5. Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
6. Vitamin D Guidelines Too Low for Cystic Fibrosis Kids
7. Children with cystic fibrosis not well covered by guidelines for vitamin D needs
8. Mucous breakthrough in mice holds promise for cystic fibrosis
9. Five States Step Up Efforts to Screen Newborns for Cystic Fibrosis
10. Cystic Fibrosis Foundation Hosts Quality Improvement Summit - Caregivers from 15 States and Canada Gather in Hartford for Intensive Learning
11. GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , ... March 23, 2017 ... ... Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance, ... ET, http://www.fdanews.com/mdclineval                  , How will the new EU MDR language ...
(Date:3/23/2017)... ... 23, 2017 , ... News Advisory/Interview Opportunity , After six years of advocacy, ... in Europe for public health and the environment and is calling on the United ... and the overwhelming support of European citizens, the European Union (EU) will, beginning next ...
(Date:3/23/2017)... ... March 23, 2017 , ... “My Journey Through Heaven”: ... with an infinitely more profound faith of God’s promise of Heaven for His people. ... who spends each day with his wife, three children and six grandchildren living and ...
(Date:3/23/2017)... ... March 23, 2017 , ... “The Trainer”: an electrifying and ... Scotty, a fiction writer with an active imagination and an enthusiasm for action and ... the tale of Wild Bill Hart, who sat looking at the thirty-three notches that ...
(Date:3/22/2017)... , ... March 23, 2017 , ... Death anxiety is ... by profession, author Joy Nugent was inspired to write the book titled “ As ... her inward desire to make sense of what she was experiencing at the bedside ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... , March 23, 2017 ... ended the trading session at 5,821.64, up 0.48%; ... to finish at 20,661.30; and the S&P 500 ... broad based as six out of nine sectors ... has initiated reports coverage on the following Medical ...
(Date:3/23/2017)... March 23, 2017 ... Enterprises Limited, gibt die Ernennung von Stuart ... bietet seinen globalen Pharmazeutikkunden eine einmalige integrierte ... wichtige Rolle für das erfolgreiche Wachstum und ... Leiter wird Herr Needleman dafür verantwortlich sein, ...
Breaking Medicine Technology: